Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

16. April 2014 16:00 ET | Quelle: Relypsa, Inc.

Relypsa, Inc. Announces Closing of Public Offering of Common Stock

REDWOOD CITY, Calif., April 16, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the closing of its public offering of 4,130,611 shares of its common...
10. April 2014 23:50 ET | Quelle: Relypsa, Inc.

Relypsa, Inc. Announces Pricing of Public Offering of Common Stock

REDWOOD CITY, Calif., April 10, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the pricing of an underwritten public offering of 3,591,836 shares of...
08. April 2014 16:05 ET | Quelle: Relypsa, Inc.

Relypsa, Inc. Announces Proposed Public Offering of Common Stock

REDWOOD CITY, Calif., April 8, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced it has commenced an underwritten public offering of shares of its...
02. April 2014 09:00 ET | Quelle: Relypsa, Inc.

Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs

REDWOOD CITY, Calif., April 2, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Sylvia R. Wheeler to the position of Vice...
17. März 2014 16:05 ET | Quelle: Relypsa, Inc.

Relypsa Announces Fourth Quarter and Full Year 2013 Financial Results

REDWOOD CITY, Calif., March 17, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq: RLYP), a biopharmaceutical company, today reported financial results for the fourth quarter and year ended December 31,...
26. Februar 2014 09:00 ET | Quelle: Relypsa, Inc.

Relypsa to Present at Two Upcoming Investor Conferences in March

REDWOOD CITY, Calif., Feb. 26, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will present a corporate...
04. Februar 2014 16:00 ET | Quelle: Relypsa, Inc.

Relypsa Completes Enrollment of Phase 1 Onset-of-Action Study for Patiromer

REDWOOD CITY, Calif., Feb. 4, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a clinical-stage biopharmaceutical company, today announced that patient enrollment for its Phase 1 onset-of-action...
03. Februar 2014 09:00 ET | Quelle: Relypsa, Inc.

Relypsa to Present at BIO CEO Conference February 10

REDWOOD CITY, Calif., Feb. 3, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a clinical-stage biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will speak at...
13. Januar 2014 09:00 ET | Quelle: Relypsa, Inc.

Relypsa Provides Corporate Update

REDWOOD CITY, Calif., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a clinical-stage biopharmaceutical company, today provided a corporate update including new data on the...
20. November 2013 16:05 ET | Quelle: Relypsa, Inc.

Relypsa, Inc. Announces Closing of Initial Public Offering

REDWOOD CITY, Calif., Nov. 20, 2013 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a clinical-stage biopharmaceutical company, today announced the closing of its initial public offering of 7,877,500...

Vorherige Seite